Clinical Trial Update: A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating LB1148 for return of bowel function in subjects undergoing bowel resection was terminated. The results were posted on 2024-06-13.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Disorders
• Ileus

Drugs mentioned

• LB1148 (LB1148)

Snippet

Sponsor: Palisade Bio | Conditions: Ileus, Gastro-Intestinal Disorder | Phase 3 | Status: TERMINATED | Results posted: 2024-06-13